Extracellular ATP can produce various effects acting via P-2-purinocep
tors. ATP is rapidly broken down by ecto-ATPase and other ecto-enzymes
that limit its effect. Further, adenosine, a metabolite of ATP breakd
own, can produce its own effect acting via P-1-purinoceptors, sometime
s masking the effects of ATP. An inhibitor of ATP degradation would be
a useful pharmacological tool to discriminate between effects of ATP
and its metabolites, as well as to potentiate its actions. Diverse com
pounds that have been claimed to be inhibitors of ATP-metabolising ect
oenzymes are evaluated, but specific and selective Ca2+/Mg2+-dependent
ecto-ATPase inhibitors still appear to be lacking. (C) 1994 Wiley-Lis
s, Inc.